로딩 중…
지수 로딩 중…
Sana Biotechnology, Inc.
SANA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$3.16+3.95%
2026-06-18
Price Chart
Sana Biotechnology, Inc.+14.49%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $879M |
| Revenue | $0.00 |
| Net Income | $-242M |
| Total Assets | $374M |
| Net Assets | $119M |
| Value | |
| P/B | 7.38x |
| FCF Yield | -15.20% |
| Profitability | |
| ROA | -64.77% |
| Financial Health | |
| Debt Ratio | 213.31% |
| Total Debt | $75M |
| FCF | $-134M |
| Cash | $84M |
| Current Ratio | 1.29x |
| Performance | |
| 1Y Return | 14.49% |
| 1M Return | 3.27% |
| From 52W High | -51.76% |
| 1Y MDD | -54.73% |
| Trading | |
| Volume | 4,705,674 shares |
| Trading Value | $15M |
| Per Share | |
| EPS | $-0.96 |
| BPS | $0.64 |